Aurinia holders back board, auditor and pay plan
Aurinia Pharmaceuticals Inc. reported the results of its 2026 annual general meeting, held virtually.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aurinia Pharmaceuticals Inc. reported the results of its 2026 annual general meeting, held virtually. Shareholders elected Kevin Tang, Jeffrey Bailey, Kathy Goetz, Craig Johnson and Tina S. Nova to the board of directors, with support for each nominee ranging from 86.50% to 96.59% of votes cast.
Shareholders also approved the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm, with 89.14% of votes cast in favor. In addition, they approved, on a non-binding advisory basis, the company’s executive compensation in a “say on pay” vote, with 93.10% of votes cast supporting the resolution.
8-K Event Classification
Key Figures
Key Terms
broker non-votes financial
independent registered public accounting firm financial
non-binding advisory basis financial
say on pay financial
broker Non-Votes financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which directors were elected to Aurinia Pharmaceuticals’ (AUPH) board in 2026 and with what support?
What was the outcome of Aurinia Pharmaceuticals’ (AUPH) 2026 say-on-pay vote?
Were there broker non-votes at Aurinia Pharmaceuticals’ (AUPH) 2026 annual meeting?
AI-generated analysis. How Rhea-AI works. Not financial advice.